Gsk Plc · LSE:GSK

Gsk — Corporate Update (May 2012)

6 slides from Gsk's corporate update, May 2012

  1. Slide 1: GSK Verona Presentation Pack

    GSK Verona Presentation Pack May 2012

  2. Slide 2: GSK Verona

    GSK Verona  Sterile vial fill and packaging Manufacturer of cephalosporin products for GSK and 3rd parties  Global Supplier for Sterile Cephalosporins  Flexible Partner, focused on Customer’s needs, ensuring quick responses and smart solutions  Reliable Organization, recognized for the highest q

  3. Slide 3: Brief Description of Site Capabilities

    Brief Description of Site Capabilities  4 aseptic filling lines equipped with the most advanced technologies and complying with the most stringent regulatory requirements;  Filling capability to cover a wide range of vial sizes: 10ml, 17ml, 26ml, 60ml, 77ml, 127ml plus Add- Vantage presentations;

  4. Slide 4: Verona Regulatory Accreditations

    Verona Regulatory Accreditations  Approval by all major Regulatory agencies: European Union, USA, Japan, Canada, Brazil, etc.  FDA approval for sterile dosage since 1983;  Last FDA inspection received in 2011 with no 483;  High Protected Risk (HPR) Site certification since 2001;  Regulatory app

  5. Slide 5: GMS Verona – Performance Profile

    GMS Verona – Performance Profile Regulatory and compliance profile External inspections with no critical observation since 2004 GMS Verona never experience a recall related site operations Customer service Long records of delivery performance > 98% ( delivery time +/- 3 days ) Patient profile Justif

  6. Slide 6: GMS Verona - Products

    GMS Verona - Products ACTIVE Ingredient Dose Form Brand Name Vials for injection (17,26ml) Zinacef Sodium Cefuroxime Vials for infusion (77,127ml) Curoxim Monovial (18ml)/Advantage (22ml) Vials for injection (17,26 ml) Vials for infusion (60, 77,127 ml) Fortaz/Fortum Ceftazidime Glazidim Monovial (1

GSK — Corporate Update (May 2012) on 6ix